文献速递主动脉疾病

后桌修改支架移植物用于升主动脉腔内修复

Back-Table Modified Stent-Graft for Endovascular Repair of Ascending Aorta.
PubMed 文献 · J Endovasc Ther · 2021-06-30

该回顾性研究纳入2015年1月至2019年12月31例接受升主动脉腔内修复的患者,术中根据主动脉造影在后桌对市售胸主动脉支架移植物进行开窗或截断修改。30天死亡率为12.9%,主动脉相关死亡率为6.5%;平均随访28.8±16.6个月,1年和3年总体生存率均为80.6%。结论认为后桌修改支架移植物是高风险患者升主动脉腔内修复的可行选择,结局可接受。

要点

  • 后桌修改支架移植物可用于治疗升主动脉多种病变,包括A型夹层、穿透性溃疡等
  • 30天死亡率为12.9%,主动脉相关死亡率为6.5%,围术期卒中2例
  • 1年和3年总体生存率均为80.6%,无不良事件率分别为88.9%和84.7%

核心结论

  • 后桌修改支架移植物用于升主动脉腔内修复是高风险患者的可行替代方案,结局可接受。

研究设计与样本

  • 回顾性研究,2015年1月至2019年12月共31例患者接受升主动脉腔内修复,使用后桌修改的支架移植物。
  • 修改方式为根据术中主动脉造影对市售胸主动脉支架移植物进行开窗或截断技术。
  • 病变包括急性(n=4)或慢性(n=1)A型主动脉夹层、穿透性主动脉溃疡(n=18)、假性动脉瘤(n=2)、吻合口瘘(n=1)及TEVAR后内漏(n=5)。

主要发现

  • 30天死亡率为12.9%,主动脉相关死亡率为6.5%。
  • 住院期间发生2例卒中、3例呼吸功能不全和6例内漏。
  • 平均随访28.8±16.6个月,1年和3年总体生存率均为80.6%。
  • 1年和3年无不良事件率分别为88.9%和84.7%。
  • 随访期间2例死亡:1例出院后1个月死于恶病质,另1例出院后3个月死于急性心肌梗死;1例假性动脉瘤患者因Ia型内漏在出院后3个月接受开放升主动脉置换;另1例患者出院后17个月发生小脑梗死。

临床怎么用

  • 对于高风险升主动脉病变患者,可考虑采用后桌修改支架移植物进行腔内修复。
  • 术中需根据主动脉造影个体化设计开窗或截断,以适配升主动脉解剖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the effectiveness of modified stent-grafts (SGs) for the management of ascending aortic pathologies. MATERIALS AND METHODS: From January 2015 to December 2019, 31 individuals were treated by ascending aortic endovascular repair with a back-table modified SG for acute (n=4) or chronic (n=1) type A aortic dissections, penetrating aortic ulcers (n=18), pseudoaneurysms (n=2), anastomotic fistula (n=1), and endoleaks after thoracic endovascular aortic repair (TEVAR) (n=5). The commercially available thoracic aortic SGs were modified with a fenestration or truncation technique on the back-table according to aortography during the operation. RESULTS: The 30-day mortality and aorta-related mortality rates were 12.9% and 6.5%, respectively. There were 2 strokes, 3 respiratory insufficiencies, and 6 endoleaks during hospitalization. During a mean follow-up of 28.8±16.6 months, the overall survival rates at 1 year and 3 years were both 80.6%. Free from adverse event rates at 1 year and 3 years were 88.9% and 84.7%, respectively. There were 2 deaths during follow-up: One patient died of cachexia 1 month after discharge, and the other patient died of acute myocardial infarction 3 months after discharge. One patient with a pseudoaneurysm underwent open ascending aorta replacement 3 months after discharge for a type Ia endoleak. Another patient suffered from cerebellar infarction 17 months after discharge. CONCLUSION: The modified SG for endovascular repair of the ascending aorta is a practicable alternative and presents acceptable outcomes in high-risk patients.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Shi J, Liu L, Wei X, et al. Back-Table Modified Stent-Graft for Endovascular Repair of Ascending Aorta. J Endovasc Ther. 2021. PMID: 34190632. doi:10.1177/15266028211028201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。